[Translation] A randomized, open-label, three-period, three-sequence, partially repeated crossover bioequivalence study of simvastatin tablets in healthy volunteers with fasting and postprandial administration
(1)通过辛伐他汀片空腹和餐后给药的生物等效性研究,评价上海信谊万象药业股份有限公司生产的辛伐他汀片(规格:20mg)与Merck Sharp & Dohme B.V.(持证商)的辛伐他汀片(规格:20mg)的生物等效性,为上海信谊万象药业股份有限公司生产的辛伐他汀片与Merck Sharp & Dohme B.V.(持证商)的辛伐他汀片临床疗效的一致性提供证据。
(2)对辛伐他汀片的安全性进行评价。
[Translation] (1) The bioequivalence study of simvastatin tablets administered on an empty stomach and after a meal was conducted to evaluate the bioequivalence of simvastatin tablets (specification: 20 mg) produced by Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. and simvastatin tablets (specification: 20 mg) produced by Merck Sharp & Dohme B.V. (licensed manufacturer), and to provide evidence for the consistency of clinical efficacy between simvastatin tablets produced by Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. and simvastatin tablets produced by Merck Sharp & Dohme B.V. (licensed manufacturer).
(2) The safety of simvastatin tablets was evaluated.